entertainment -WSS

entertainment

author：hotspot 2025-09-29 21:26:46 - browse：8

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Boston Scientific acquires urology company Axonics for $3.7 billion

WSS

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Carbon Health diabetes program, a test of data

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

FDA early review: GLP

After decades in use, heart stents finally beat placebo

Arena BioWorks launches in Cambridge to speed drug discovery

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medical school prerequisites are outdated

DIEP, the 'gold standard' of breast reconstruction, is under threat

Experimental asthma app from Apple and Anthem shows promise

Wildfire smoke exposes gaps in outdoor worker protections

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Medicare details structure of new drug price negotiation program

Medicare’s new pay boost for primary care is angering specialists

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A preacher's new calling: Diversifying neuroscience research

focus

American taxpayers paid $1.8 trillion in health care costs in 2022

Today's health inequities arise from racist U.S. history, say experts

A letter from the executive editor: STAT UnitedHealth investigation

At JPM 2024, hospital systems pitch financial strength to investors

Publishing genetic code of viruses could cause disaster

Profiling embryos to choose those with higher IQs is almost a reality

entertainment

explore

knowledge

leisure time